Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation

Area of Science:

• Oncology
• Virology
• Molecular Biology

Background:

• Cervical carcinoma is frequently driven by human papillomavirus (HPV) oncoproteins E6 and E7.
• In established cell lines, HPV E6 and E7 repression triggers senescence via tumor suppressor pathways.

Purpose of the Study:

• To investigate if primary cervical carcinoma cells require sustained HPV16 or HPV18 oncogene expression for proliferation.
• To assess the role of HPV oncogenes in primary cervical cancer cell growth under serum-free conditions.

Main Methods:

• Primary cervical carcinoma cells were isolated and cultured at low passage numbers.
• SV40 viral vectors delivering bovine papillomavirus E2 protein were used to repress HPV E6 and E7.
• Cells were pre-treated with ganglioside GM1 to enhance SV40 infection and E2 delivery.

Main Results:

• Repression of HPV oncogenes in primary cervical cancer cells led to cellular senescence.
• The E2 protein had minimal impact on HPV-negative primary cells, indicating specificity.
• These findings highlight the critical role of HPV E6 and E7 in driving cancer cell proliferation.

Conclusions:

• Ongoing expression of HPV E6 and E7 oncogenes is indispensable for the proliferation of primary human cervical carcinoma cells.
• Cervical cancer cells exhibit an inherent dependence on HPV E6 and E7 for sustained growth.
• Targeting HPV oncogenes represents a potential therapeutic strategy for cervical cancer.